Thyroid Cancer Diagnostics Market, By Product (Instruments and Kits & consumables), By Type, By Technique, By End-User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4178
|
Published Date
July 2025
|
Pages
392
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Thyroid Cancer Diagnostics Market size was valued at US$ 3,167.24 Million in 2024, expanding at a CAGR of 5.5% from 2025 to 2032.
The diagnosis of thyroid cancer involves a comprehensive series of tests designed to detect and confirm the presence of cancer in the thyroid gland. This diagnostic process typically includes physical examinations, blood tests, imaging techniques, biopsy procedures, and molecular or genetic analyses. Accurate and timely diagnosis is essential for developing effective treatment plans and improving patient outcomes and survival rates. Advanced diagnostic tools play a critical role in the early detection and classification of thyroid tumors, enabling personalized and targeted therapeutic approaches.
Thyroid Cancer Diagnostics Market- Market Dynamics
Rising Prevalence of Thyroid Cancer Expected to Drive Market Growth
As the incidence of thyroid cancer continues to rise, there is an increasing demand for early and accurate diagnostic solutions. This trend is driving the adoption of advanced imaging techniques, molecular diagnostics, and minimally invasive biopsy procedures—key tools for accurate disease detection, classification, and the development of personalized treatment plans. In the United States alone, approximately 53,000 people are diagnosed with thyroid cancer each year. While treatment outcomes are generally favorable, the disease still accounts for around 2,000 deaths annually. Additionally, growing healthcare expenditures and the expansion of cancer screening initiatives are expected to create significant market opportunities. However, the high cost of advanced diagnostic technologies may pose a barrier to broader adoption and market growth.
Thyroid Cancer Diagnostics Market- Segmentation Analysis:
The Global Thyroid Cancer Diagnostics Market is segmented based on Product, Type, Technique, End-User, and Region.
The Thyroid Cancer Diagnostics market is segmented into three main product categories: Instruments, Kits, and Consumables, with Instruments leading market growth. Instruments, including advanced imaging systems, molecular diagnostic tools, and biopsy devices, are vital for the accurate and efficient detection of thyroid malignancies. Their increasing use in hospitals, diagnostic centers, and research laboratories is driven by their ability to facilitate early diagnosis and monitor disease progression, which is critical for improving patient outcomes. According to the World Health Organization (WHO), thyroid cancer incidence has been rising globally, with over 586,000 new cases reported in 2020, prompting governments worldwide to invest in advanced diagnostic technologies to improve detection and management of the disease. This governmental focus on early cancer diagnosis continues to fuel demand for sophisticated instruments in clinical settings.
The market is further segmented by thyroid cancer type into Papillary carcinoma, Follicular carcinoma, and others, with Papillary carcinoma dominating market growth. This subtype accounts for the majority of thyroid cancer diagnoses due to its high prevalence, especially among women and populations in countries with advanced healthcare infrastructures. The increasing incidence of papillary carcinoma has intensified the need for precise and early diagnostic solutions tailored to this specific cancer type. The International Agency for Research on Cancer (IARC) reports that papillary thyroid carcinoma represents about 80% of all thyroid cancer cases globally, underscoring the critical role of governments in supporting specialized diagnostic programs and awareness campaigns to address this growing health concern.
In terms of diagnostic technique, the market is categorized into Blood tests, Imaging, Biopsy, and others, with Imaging techniques serving as the primary driver of growth. Imaging modalities such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are widely adopted due to their non-invasive nature and ability to provide detailed anatomical and functional insights. Among these, ultrasound remains the most commonly used technique for initial thyroid nodule assessment due to its accessibility, cost-effectiveness, and diagnostic accuracy. Global health agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have emphasized the importance of imaging in thyroid cancer diagnostics, leading to widespread government initiatives to integrate these technologies into national cancer screening programs, particularly in developed countries.
Finally, the market is segmented by end-user into Hospitals, Cancer Diagnostic Centers, Academic and Research Institutes, and others, with Hospitals taking the lead. Hospitals dominate the market due to their comprehensive diagnostic infrastructure, availability of cutting-edge technologies, and multidisciplinary teams of specialists required for effective thyroid cancer detection and treatment. These institutions serve as the primary points for cancer screening and patient care, managing a growing number of cases due to increased screening efforts worldwide. According to the Global Cancer Observatory (GLOBOCAN), healthcare spending on cancer diagnostics has risen significantly, with hospitals receiving increased funding to upgrade diagnostic capabilities. Governments in regions such as North America, Europe, and Asia-Pacific continue to prioritize hospital-based cancer diagnostics as part of their broader public health strategies to reduce thyroid cancer mortality rates through early detection and timely treatment.
Thyroid Cancer Diagnostics Market- Geographical Insights
North America leads the market growth, driven primarily by advancements in cancer diagnostic technologies. The region benefits from a well-established healthcare infrastructure, widespread access to advanced imaging systems, and strong adoption of molecular diagnostic tools such as next-generation sequencing (NGS) and polymerase chain reaction (PCR). In the United States alone, there are an estimated 1.9 million new cancer diagnoses and 609,360 deaths annually. The use of established diagnostic methods—including positron emission tomography (PET), computed tomography (CT), and magnetic resonance spectroscopy (MRS)—in combination with molecular diagnostics, has significantly improved early detection rates. These technologies play a vital role not only in cancer treatment management but also in the early identification of the disease. Europe ranks as the second-largest market, supported by high public awareness, robust healthcare systems, and favorable government policies.
Thyroid Cancer Diagnostics Market- Competitive Landscape:
The thyroid cancer diagnostics market is highly competitive, featuring established diagnostic leaders, specialized biotechnology firms, and emerging startups. Companies are continually innovating to enhance diagnostic accuracy, reduce turnaround times, and expand their global presence. Key players are investing heavily in next-generation sequencing (NGS), AI-powered imaging, and molecular diagnostic technologies to gain a competitive edge. Additionally, many firms are targeting emerging markets such as Asia-Pacific, Latin America, and the Middle East, capitalizing on the rising incidence of thyroid cancer and increasing healthcare infrastructure investments in these regions.
Recent Developments:
- Thermo Fisher Scientific announced that its in vitro diagnostic test, Oncomine, has received FDA approval as a companion diagnostic for grade 2 IDH-mutant glioma.
- On August 3, 2021, NorthStar Medical Radioisotopes, LLC, a global leader in radiopharmaceutical innovation and commercialization, announced an exclusive agreement with GE Healthcare for the manufacturing and distribution of iodine-123 (I-123) capsules within the United States.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL THYROID CANCER DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- F. HoffmannLaRoche Ltd (Roche Diagnostics)
- Siemens Healthineers
- Thermo Fisher Scientific
- GE HealthCare
- BioRad Laboratories
- Agilent Technologies
- Philips Healthcare
- Illumina, Inc.
- Daiichi Sankyo
- Hologic, Inc.
- Becton Dickinson
- PerkinElmer, Inc.
- Qiagen N.V.
- Veracyte, Inc.
- Exact Sciences
- NeoGenomics
- DiaSorin S.p.A.
- Guardant Health
- Myriad Genetics
- Others
GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Instruments
- Kits & consumables
GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Papillary carcinoma
- Follicular carcinoma
- Other
GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032
- Blood test
- Imaging
- Biopsy
- Other
GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Cancer diagnostic centers
- Academic and research institutes
- Other
GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Thyroid Cancer Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Thyroid Cancer Diagnostics Market Snippet by Product
2.1.2. Thyroid Cancer Diagnostics Market Snippet by Type
2.1.3. Thyroid Cancer Diagnostics Market Snippet by Technique
2.1.4. Thyroid Cancer Diagnostics Market Snippet by End-User
2.1.5. Thyroid Cancer Diagnostics Market Snippet by Country
2.1.6. Thyroid Cancer Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Thyroid Cancer Diagnostics Key Market Trends
3.1. Thyroid Cancer Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Thyroid Cancer Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Thyroid Cancer Diagnostics Market Opportunities
3.4. Thyroid Cancer Diagnostics Market Future Trends
4. Thyroid Cancer Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Thyroid Cancer Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Thyroid Cancer Diagnostics Market Landscape
6.1. Thyroid Cancer Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Thyroid Cancer Diagnostics Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Instruments
7.1.3. Kits & consumables
8. Thyroid Cancer Diagnostics Market – By Type
8.1. Overview
8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
8.1.2. Papillary carcinoma
8.1.3. Follicular carcinoma
8.1.4. Other
9. Thyroid Cancer Diagnostics Market – By Technique
9.1. Overview
9.1.1. Segment Share Analysis, By Technique, 2024 & 2032 (%)
9.1.2. Blood test
9.1.3. Imaging
9.1.4. Biopsy
9.1.5. Other
10. Thyroid Cancer Diagnostics Market – By End-User
10.1. Overview
10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Cancer diagnostic centers
10.1.4. Academic and research institutes
10.1.5. Other
11. Thyroid Cancer Diagnostics Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Thyroid Cancer Diagnostics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Thyroid Cancer Diagnostics Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Thyroid Cancer Diagnostics Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Thyroid Cancer Diagnostics Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Thyroid Cancer Diagnostics Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Thyroid Cancer Diagnostics Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Abbott Laboratories
12.2.2. F. HoffmannLaRoche Ltd (Roche Diagnostics)
12.2.3. Siemens Healthineers
12.2.4. Thermo Fisher Scientific
12.2.5. GE HealthCare
12.2.6. BioRad Laboratories
12.2.7. Agilent Technologies
12.2.8. Philips Healthcare
12.2.9. Illumina, Inc.
12.2.10. Daiichi Sankyo
12.2.11. Hologic, Inc.
12.2.12. Becton Dickinson
12.2.13. PerkinElmer, Inc.
12.2.14. Qiagen N.V.
12.2.15. Veracyte, Inc.
12.2.16. Exact Sciences
12.2.17. NeoGenomics
12.2.18. DiaSorin S.p.A.
12.2.19. Guardant Health
12.2.20. Myriad Genetics
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
